How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Capital And GraftAssureDx Milestones [Yahoo! Finance]
Insight Molecular Diagnostics Inc. (IMDX)
Company Research
Source: Yahoo! Finance
The updated analyst narrative on Insight Molecular Diagnostics now centers on a fresh price target of $12 per share, while the internal fair value estimate remains at $8.33. Analysts linking this move to the recent $26m capital raise and the expected FDA submission for GraftAssureDx see funding visibility and a clearer regulatory path as key drivers of the higher target, with others still cautious about execution and approval risk. As you read on, you will see how these competing views shape the evolving story around Insight Molecular Diagnostics and what to watch next. Stay updated as the Fair Value for Insight Molecular Diagnostics shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Insight Molecular Diagnostics. What Wall Street Has Been Saying ?? Bullish Takeaways Lake Street raised its price target on Insight Molecular Diagnostics to $12 from $8, indicating that the firm now sees more upside in the sha
Show less
Read more
Impact Snapshot
Event Time:
IMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMDX alerts
High impacting Insight Molecular Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
IMDX
News
- iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare ConferenceGlobeNewswire
- Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score [Yahoo! Finance]Yahoo! Finance
- Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model ScoreGlobeNewswire
- Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]Yahoo! Finance
IMDX
Sec Filings
- 2/26/26 - Form 8-K
- 2/12/26 - Form SCHEDULE
- 2/12/26 - Form 4
- IMDX's page on the SEC website